Ryan Langston
Stock Analyst at TD Cowen
(0.96)
# 3,930
Out of 4,988 analysts
258
Total ratings
46.1%
Success rate
-1.5%
Average return
Main Sectors:
Stocks Rated by Ryan Langston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SGRY Surgery Partners | Rated: Buy | $19 | $13.25 | +43.40% | 13 | Sep 18, 2026 | |
| PIII P3 Health Partners | Reiterated: Hold | $13 | $7.67 | +69.49% | 12 | Aug 26, 2026 | |
| EHC Encompass Health | Rated: Buy | $125 → $140 | $121.75 | +14.99% | 3 | Aug 10, 2026 | |
| AGL agilon health | Reiterated: Hold | $55 → $95 | $89.16 | +6.55% | 11 | Aug 7, 2026 | |
| DVA DaVita | Upgraded: Buy | $201 → $220 | $183.86 | +19.66% | 12 | Aug 7, 2026 | |
| ADUS Addus HomeCare | Rated: Buy | $131 | $117.07 | +11.90% | 23 | Aug 4, 2026 | |
| ALHC Alignment Healthcare | Rated: Buy | $25 → $21 | $8.35 | +151.50% | 10 | Aug 3, 2026 | |
| HUM Humana | Rated: Hold | $350 → $370 | $386.22 | -4.20% | 16 | Jul 31, 2026 | |
| ACHC Acadia Healthcare Company | Reiterated: Buy | $36 | $28.33 | +27.07% | 16 | Jul 30, 2026 | |
| CNC Centene | Rated: Hold | $65 | $65.11 | -0.17% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $197 | $176.69 | +11.49% | 17 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $431 | $427.71 | +0.77% | 16 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $230 → $200 | $200.79 | -0.39% | 19 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $233 → $263 | $261.99 | +0.39% | 9 | Jul 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $430 | $376.90 | +14.09% | 18 | Jul 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $400 → $465 | $410.95 | +13.15% | 15 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 → $50 | $34.36 | +45.52% | 13 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $19.85 | +51.13% | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $391 → $333 | $275.28 | +20.97% | 4 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 | $12.57 | n/a | 1 | Aug 9, 2024 |
Surgery Partners
Sep 18, 2026
Rated: Buy
Price Target: $19
Current: $13.25
Upside: +43.40%
P3 Health Partners
Aug 26, 2026
Reiterated: Hold
Price Target: $13
Current: $7.67
Upside: +69.49%
Encompass Health
Aug 10, 2026
Rated: Buy
Price Target: $125 → $140
Current: $121.75
Upside: +14.99%
agilon health
Aug 7, 2026
Reiterated: Hold
Price Target: $55 → $95
Current: $89.16
Upside: +6.55%
DaVita
Aug 7, 2026
Upgraded: Buy
Price Target: $201 → $220
Current: $183.86
Upside: +19.66%
Addus HomeCare
Aug 4, 2026
Rated: Buy
Price Target: $131
Current: $117.07
Upside: +11.90%
Alignment Healthcare
Aug 3, 2026
Rated: Buy
Price Target: $25 → $21
Current: $8.35
Upside: +151.50%
Humana
Jul 31, 2026
Rated: Hold
Price Target: $350 → $370
Current: $386.22
Upside: -4.20%
Acadia Healthcare Company
Jul 30, 2026
Reiterated: Buy
Price Target: $36
Current: $28.33
Upside: +27.07%
Centene
Jul 30, 2026
Rated: Hold
Price Target: $65
Current: $65.11
Upside: -0.17%
Jul 29, 2026
Rated: Buy
Price Target: $197
Current: $176.69
Upside: +11.49%
Jul 27, 2026
Rated: Buy
Price Target: $431
Current: $427.71
Upside: +0.77%
Jul 27, 2026
Rated: Hold
Price Target: $230 → $200
Current: $200.79
Upside: -0.39%
Jul 27, 2026
Rated: Buy
Price Target: $233 → $263
Current: $261.99
Upside: +0.39%
Jul 19, 2026
Reiterated: Hold
Price Target: $430
Current: $376.90
Upside: +14.09%
Jul 17, 2026
Reiterated: Buy
Price Target: $400 → $465
Current: $410.95
Upside: +13.15%
Jul 14, 2026
Rated: Buy
Price Target: $45 → $50
Current: $34.36
Upside: +45.52%
May 11, 2026
Reiterated: Buy
Price Target: $30
Current: $19.85
Upside: +51.13%
Feb 4, 2026
Reiterated: Buy
Price Target: $391 → $333
Current: $275.28
Upside: +20.97%
Aug 9, 2024
Rated: Hold
Price Target: $7
Current: $12.57
Upside: n/a